IVF Stock Analysis: Buy, Sell, or Hold?
IVF - INVO Fertility, Inc. Common Stock
$2.45
1.21 (97.58%)
β²
5d:
+63.33%
30d:
+53.12%
90d:
+324.61%
WAIT
LOW Confidence
Analysis Updated: Jun 26, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When IVF Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR BETTER ENTRY: IVF is 37.6% above its trading range ($1.78). While momentum could continue, risk/reward favors waiting for a pullback.
βΈοΈ WAIT FOR BETTER ENTRY: IVF is 37.6% above its trading range ($1.78). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: IVF is currently trading at $2.45, which is considered extended relative to its 30-day fair value range of $1.33 to $1.78.
Technical Outlook: Technically, IVF is in a uptrend. The price is approaching resistance at $2.08. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 97.6% recently.
Market Sentiment: IVF has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $20.00 (+716.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IVF is in a uptrend. The price is approaching resistance at $2.08. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 97.6% recently.
Market Sentiment: IVF has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $20.00 (+716.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.33 -
$1.78
Company Quality Score
54/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
52.6%
All Signals
- BEARISH: Price significantly overextended (+37.6% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: Strong upward momentum (+97.6%)
- BULLISH: Trading 716.3% below Wall St target ($20.00)
- WARNING: Recommendation downgraded due to 37.6% overvaluation
Trading Range Analysis
30-Day Trading Range
$1.33 -
$1.78
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.27
Resistance Level
$2.08
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.31
Wall Street Target
$20.00
(+716.3%)
Revenue Growth (YoY)
23.1%
Profit Margin
-158.7%
Share & Embed Analysis
Last updated: June 27, 2026 5:13 AM ET
Data refreshes hourly during market hours. Next update: 6:13 AM
Data refreshes hourly during market hours. Next update: 6:13 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IVF showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 65 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 68 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 64 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 61 BUY |
|
ZBH
Zimmer Biomet Holdings I⦠|
HOLD
29 analysts |
$99 | 66 BUY |